Federated Learning Enables Big Data for Rare Cancer Boundary Detection
  Although machine learning (ML) has shown promise in numerous domains, there
are concerns about generalizability to out-of-sample data. This is currently
addressed by centrally sharing ample, and importantly diverse, data from
multiple sites. However, such centralization is challenging to scale (or even
not feasible) due to various limitations. Federated ML (FL) provides an
alternative to train accurate and generalizable ML models, by only sharing
numerical model updates. Here we present findings from the largest FL study
to-date, involving data from 71 healthcare institutions across 6 continents, to
generate an automatic tumor boundary detector for the rare disease of
glioblastoma, utilizing the largest dataset of such patients ever used in the
literature (25,256 MRI scans from 6,314 patients). We demonstrate a 33%
improvement over a publicly trained model to delineate the surgically
targetable tumor, and 23% improvement over the tumor's entire extent. We
anticipate our study to: 1) enable more studies in healthcare informed by large
and diverse data, ensuring meaningful results for rare diseases and
underrepresented populations, 2) facilitate further quantitative analyses for
glioblastoma via performance optimization of our consensus model for eventual
public release, and 3) demonstrate the effectiveness of FL at such scale and
task complexity as a paradigm shift for multi-site collaborations, alleviating
the need for data sharing.
